September 23, 2014 8:39 AM ET

Pharmaceuticals

Company Overview of Catalent Pharma Solutions, Inc.

Company Overview

Catalent Pharma Solutions, Inc. provides development solutions and delivery technologies for drugs, biologics, and consumer health products. The company’s Development and Clinical Services segment offers manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also provides analytical chemical and cell-based testing and scientific services; respiratory products formulation and manufacturing; regulatory consulting; and bioanalytical testing for biologic products. Its Oral Technologies segment offers oral delivery technologies, including formulation, development, and manufacturing services for the oral dose forms comprising p...

14 Schoolhouse Road

Somerset, NJ 08873

United States

8,300 Employees

Phone:

732-537-6200

Fax:

732-537-6480

Key Executives for Catalent Pharma Solutions, Inc.

Chief Executive Officer
Age: 50
Chief Financial Officer
Age: 47
Senior Vice President of Global Operations
Age: 52
Group President of Oral Technologies and Head of Oral Technologies Business
Age: 53
President of Oral Technologies - Softgel
Age: 58
Compensation as of Fiscal Year 2014.

Catalent Pharma Solutions, Inc. Key Developments

Catalent Pharma Solutions, Inc. to Redeem €225.0 Million Outstanding 9.75% Senior Subordinated Notes Due 2017

On August 5, 2014, Catalent Pharma Solutions, Inc. provided notice of its election to redeem all of the €225.0 million aggregate principal amount currently outstanding of its 9.75% Senior Subordinated Notes due 2017 (the redeemed notes). The redeemed notes will be redeemed on September 4, 2014 (the redemption date) at a redemption price (the redemption price) of 101.625% of the principal amount thereof plus accrued and unpaid interest on the redeemed notes to, but excluding, the redemption date.

Catalent Pharma Solutions, Inc. to Redeem All of the $350.0 Million Aggregate Principal Amount Currently Outstanding of its 7.875% Senior Notes Due 2018

On July 29, 2014, Catalent Pharma Solutions, Inc. provided notice of its election to redeem all of the $350.0 million aggregate principal amount currently outstanding of Catalent's 7.875% Senior Notes due 2018 (redeemed notes). The redeemed notes will be redeemed on August 28, 2014 (redemption date) at a redemption price of 101.5% of the principal amount thereof plus accrued and unpaid interest on the redeemed notes to, but excluding, the redemption date, subject to the completion of an initial public offering by Catalent's indirect parent, Catalent, Inc.

Samrat S. Khichi, Senior Vice President, Chief Administrative Officer, General Counsel and Secretary to Leave Catalent Pharma Solutions, Inc., Effective July 21, 2014

On April 28, 2014, Samrat S. Khichi, Senior Vice President, Chief Administrative Officer, General Counsel and Secretary of Catalent Pharma Solutions, Inc. notified the company of his decision to leave the company effective July 21, 2014 (the Departure Date) to serve as Senior Vice President, General Counsel and Corporate Secretary of a multinational public company. Mr. Khichi has agreed to continue to serve in his various capacities for a transition period ending on the Departure Date.

Similar Private Companies By Industry

Company Name Region
Green Roads of Florida, LLC United States
Synereca Pharmaceuticals, Inc. United States
AR Scientific, Inc. United States
Cetek Corporation United States
Transition Therapeutics (USA) Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Bankruptcy
September 16, 2014
SIGA Technologies, Inc.
Merger/Acquisition
March 24, 2014
Redwood Bioscience Inc.
Merger/Acquisition
October 9, 2013
Relthy Laboratórios Ltda.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Catalent Pharma Solutions, Inc., please visit www.catalent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.